Multidimensional nature of apomorphine SL (Ixense) therapy.
The aetiology of erectile dysfunction (ED) is multifactorial consisting of psychogenic and organic factors that must be considered in a multidisciplinary manner in order to treat effectively the disorder. New central initiators of erection such as apomorphine SL (Ixense) provide a pharmacologically multidimensional approach to the treatment of ED. When used in conjunction with a psychosexual counselling strategy designed to move patients at high risk of failure to high responder groups, it can provide an effective and safe pharmacological therapy for ED.
Costa
P
P
Hopital Doumergue 5, rue Hoche, Nimes, France. pierre.costa@chu-nimes.fr
D001058:Apomorphine / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D010413:Penis / Q000294:innervation / Q000502:physiology
D018491:Dopamine Agonists; D001058:Apomorphine